Victims Of Metal-On-Metal Hip Problems Urge FDA To Stop Metal Hip Replacement Use
On June 27-28, 2012, the U.S. Food and Drug Administration (“FDA”) convened a panel of experts to discuss metal-on-metal hip problems . A slew of recent studies and health advisories have linked metal hip replacements with high rates of revision surgery and complications such as metal ion toxicity in the bloodstream. The FDA advisory committee convened to address and further examine these concerns. The goals of the meeting included:
- Reviewing currently available data regarding metal-on-metal hip systems;
- Generating scientifically based recommendations for the clinical and patient communities on how to best communicate and mitigate risks; and
- Creating recommendations for patient follow-up.
Presenters included medical professionals, representatives from hip manufacturers, consumer advocacy groups, and other concerned parties. They evaluated the technical aspects of metal-on-metal hip implants, data for revision surgery and metal ion levels, the methods of analysis for certain studies, follow up, national health regulatory agencies guidelines, and more during the two day session. Based on the information obtained at the hearings, the advisory committee will now make a recommendation to the FDA.
Recipients Injured By Metal-On-Metal (MoM) Hips Speak Out Against Dangers of MoM Hips
During the open public portion of the hearings, many patients who suffered from metal-on-metal hip problems spoke out avidly against the devices.
Dr. Diane Zuckerman, president of the National Research Center for Women & Families, a researcher trained at Yale Medical School, chose not to receive a metal hip replacement because of the lack of data available at the time. After learning of the recent studies finding metal-on-metal hip problems and high revision rates, she commented: “Keeping these implants on the market for the next 5 years while research is being done is not an ethical decision…I believe a tragic mistake was made by allowing these products on the market without good data.”
Ann Morrison received a DePuy metal-on-metal hip replacement and experienced bilateral hip implant failure. “My implant analysis confirmed the failure of the entire articulating surfaces of the acetabular liners and femoral heads,” Morrison said. “My recommendation is for the immediate withdrawal of all present hip metal-on-metal weight bearing systems from the market until further studies identify acceptable biohazard risks.” She also called for immediate mandatory follow-up for all existing MoM hip patients.
Another patient testimonial came from Sherry Winslow, who received a J&J DePuy Pinnacle hip implant and will require revision surgery. “I’ve had 86 medical things done and I haven’t even started a revision yet,” Winslow said. “I seriously hope that you will not let any more people get these metal-on-metal hips. Take them off the market; let the people know that there is a serious problem. I’m here to make sure this doesn’t happen again.”
Bernstein Liebhard LLP hopes that the compelling and often times heart-breaking testimonials from patients suffering complications from their MOM hip implants will impact the FDA’s ultimate decision regarding the future of metal hip replacements.
How To File A Metal Hip Replacement Lawsuit
If you have a metal-on-metal hip implant and experienced complications as a result, consider joining the thousands of other patients who are filing metal hip replacement lawsuits to seek compensation for your injuries.
The hip replacement lawyers at Bernstein Liebhard LLP are actively filing cases on behalf of individuals with metal hip implants, including the DePuy ASR and Pinnacle metal-on-metal hip systems, as well as the Wright Conserve hip replacement. Find out more on the Consumer Injury Lawyers website. The firm has recovered over $3 billion on behalf of its clients, and will help you navigate the complex litigation process.
Please contact our lawyers today for a free case review by calling 1-877-779-1414.